| 5QIK: reference: Discovery of 4-Azaindole Inhibitors of TGFbetaRI as Immuno-oncology Agents., Zhang Y, Zhao Y, Tebben AJ, Sheriff S, Ruzanov M, Fereshteh MP, Fan Y, Lippy J, Swanson J, Ho CP, Wautlet BS, Rose A, Parrish K, Yang Z, Donnell AF, Zhang L, Fink BE, Vite GD, Augustine-Rauch K, Fargnoli J, Borzilleri RM, ACS Med Chem Lett. 2018 Oct 17;9(11):1117-1122. doi:, 10.1021/acsmedchemlett.8b00357. eCollection 2018 Nov 8. PMID: 30429955 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).